A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome

Clinical trial NCT00220363 · COMPLETED

Trial details

NCT number: NCT00220363
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder Syndrome

Start date: 2004-01-01
Primary completion: 2005-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.